Detalhe da pesquisa
1.
Decitabine in Older Patients with AML: Quality of Life Results of the EORTC-GIMEMA-GMDS-SG Randomized Phase III Trial.
Blood
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38717861
2.
Fast proliferating and slowly migrating non-small cell lung cancer cells are vulnerable to decitabine and retinoic acid combinatorial treatment.
Int J Cancer
; 154(6): 1029-1042, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37947765
3.
Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long-term follow-up of the EORTC-GIMEMA randomized AML-10 trial.
Am J Hematol
; 99(3): 486-489, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38174977
4.
Role of Bcl-2 inhibition in myelodysplastic syndromes.
Int J Cancer
; 152(8): 1526-1535, 2023 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36444492
5.
Clonal evolution of acute myeloid leukemia with FLT3-ITD mutation under treatment with midostaurin.
Blood
; 137(22): 3093-3104, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33598693
6.
First-in-human study of WT1 recombinant protein vaccination in elderly patients with AML in remission: a single-center experience.
Cancer Immunol Immunother
; 71(12): 2913-2928, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476127
7.
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial.
Blood
; 136(26): 3041-3050, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367545
8.
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group.
Blood
; 134(19): 1608-1618, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31554635
9.
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.
Blood
; 133(8): 840-851, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30563875
10.
Characterization of myelodysplastic syndromes progressing to acute lymphoblastic leukemia.
Ann Hematol
; 100(1): 63-78, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32556451
11.
Donor lymphocyte infusions after first allogeneic hematopoietic stem-cell transplantation in adults with acute myeloid leukemia: a single-center landmark analysis.
Ann Hematol
; 100(9): 2339-2350, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33796897
12.
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q).
Ann Hematol
; 100(6): 1463-1471, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33903952
13.
Estimating and comparing adverse event probabilities in the presence of varying follow-up times and competing events.
Pharm Stat
; 20(6): 1125-1146, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34002935
14.
Nitroreductase-Mediated Release of Inhibitors of Lysine-Specific Demethylase 1 (LSD1) from Prodrugs in Transfected Acute Myeloid Leukaemia Cells.
Chembiochem
; 21(16): 2329-2347, 2020 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32227662
15.
Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia.
Ann Hematol
; 99(7): 1551-1560, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32504186
16.
Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromes.
Genes Chromosomes Cancer
; 58(10): 689-697, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30994215
17.
DNA-hypomethylating agents as epigenetic therapy before and after allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes and juvenile myelomonocytic leukemia.
Semin Cancer Biol
; 51: 68-79, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29129488
18.
Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(4): e128-e140, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30658222
19.
Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcome.
Haematologica
; 104(1): 59-69, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171030
20.
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.
Haematologica
; 104(10): 1935-1949, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31048353